It is vital that cardiovascular risk is monitored and kept as low as possible in patients with AAV. Cardiovascular events often overlap with systemic vasculitis symptoms in patients with ...
The direct immunologic role of CD200 and CD200R in AAV pathogenesis is still unclear. However, the researchers suggested that increased inflammation during active disease may increase CD200 expression ...
Adeno-associated virus (AAV) vectors have become widely recognized as a fundamental tool in gene therapy, primarily due to their potential as a delivery system for the treatment of genetic disorders.
Separating full and empty adeno-associated virus (AAV) capsids during the manufacture of single-gene therapies remains a significant challenge. Ultracentrifugation and anion exchange chromatography ...
PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational Medicine, ...
The great hope for gene therapy is that one day it will be out of the clinic and into mainstream therapeutics. Bearing enormous potential to treat or cure disease, such technology can replace a ...
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is a transmembrane receptor found on microglia, where it modulates cell activity and survival. In addition to membrane-associated TREM2, there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results